Marja J. Willemse

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

W. Hop, W. Kamps, J. V. van Dongen, 2002, Blood.

Detection of minimal residual disease identifies differences in treatment response between TALL and precursor BALL

W. Hop, W. Kamps, M. Schrappe, 2002 .

Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease.

M. van der Burg, J. V. van Dongen, T. Szczepański, 2002, Blood.

Regenerating normal B‐cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

W. Kamps, J. V. van Dongen, T. Szczepański, 2000, British journal of haematology.